Skip to main content
. 2022 Feb 18;13:802671. doi: 10.3389/fmicb.2022.802671

TABLE 1.

IC50 and CC50 of formycin A, SMeFM, and T-705 for the propagation of influenza virus strains and for cell viability.

Compound Strain Cell IC50 (nM)* CC50 (μM)#
Formycin A A/WSN/33 MDCK 37.3 ± 21.5
MDCK 2.77 ± 0.17
SMeFM A/WSN/33 MDCK 34.1 ± 27.4
A/equine/2/Miami/63 MDCK 43.8 ± 27.7
B/Lee/40 MDCK 37.9 ± 26.6
MDCK 14.6 ± 9.7
A/WSN/33 A549 52.4 ± 1.1
A549 20.8 ± 7.7
A/WSN/33 Calu-3 24.4 ± 6.3
Calu-3 145.8 ± 41.5
T-705 A/WSN/33 MDCK 200.3 ± 11.7
MDCK >1,000

*The half-maximal inhibitory concentration (IC50) was determined from the result of the plaque assay. Average values with standard deviations from three independent experiments were shown.

#The half-maximal cytotoxic concentration (CC50) was determined from the result of the MTS assay.

Average values with standard deviations from three independent experiments were shown.